CARM1 and ovarian carcinoma: Together, these observations support that CAY10566, a SCD1 inhibitor, is effective in suppressing ovarian cancer with high expression if CARM1 in vivo, and this effect is correlated with the inhibition of cell proliferation and the induction of apoptosis.